Hansoh Pharmaceutical reports stable share capital in September

Hansoh Pharmaceutical Group Company Limited submitted its monthly return on October 2, 2025, reporting no changes in its authorized or issued share capital for the month ended September 30, 2025. The company's authorized/registered share capital remained at HK$200,000, derived from 20 billion ordinary shares with a par value of HK$0.00001 each.

The total number of issued shares also held steady at 6,055,150,070 ordinary shares. There were no movements in treasury shares, which remained at zero.

The report also noted zero coupon convertible bonds due 2026, issued on January 22, 2021, with an outstanding amount of $5,378,000. These convertibles have a subscription/conversion price of HK$56.7. As of the close of the month, 735,363 shares may be issued or transferred out of treasury pursuant to these convertibles.